François TORCHE, CEO
"A strong corporate structure is a key asset to improve the scalability of the business. Theodorus helped us improve our governance and our decision-making process in order to focus on actions that create long term value and increase the chances of a successful EXIT."
Thomas LIENARD, CEO
"Theodorus helped Bone Therapeutics as a lead investor from its seed funding until its IPO. Its managers gave us a strong support during our various funding rounds."
Investment Portfolio
7 companies
High-tech
Ongoing
Sector: High-tech
Employees: 40
Classcraft helps educators motivate learners to reach their potential through sustainable, playful learning experiences that promote growth and human connection.
Biotech
Ongoing
Sector: Biotech
Employees: 10
Apaxen is a privately-held biotechnology company, which brings new treatment options to patients in a wide range of therapeutic indications related to chronic inflammation, with a primary focus in pulmonary arterial hypertension (PAH) and other de
Biotech
Ongoing
Sector: Biotech
Employees:
Founded in August 2019 by the ULB entrepreneurial team and Theodorus, the company is based on more than 10 years of dedicated applied research on inhaled lung cancer treatment held in the laboratory of Pharmaceutics and Biopharmaceutics (LPB) of t
Medtech
Ongoing
Sector: Medtech
Employees: 10
Moonshot Health is creating a new model of healthcare that moves beyond episodic, office-based medicine to provide preventive, continuous, collaborative care through the use of digital biomarkers.
Medtech
Ongoing
Sector: Medtech
Employees: 200
Icentia is a combined medical devices and service company based in Canada. It aims at providing a line of innovative medical testing solutions for healthcare institutions.
Biotech
Ongoing
Sector: Biotech
Employees: 10
The mission of the company is to develop novel therapeutic approaches for solid cancers and inflammatory diseases. The main focus is presently on small molecules targeting selected G protein-coupled receptors.